Work

Real-world characteristics, treatment patterns, and outcomes of patients with mantle cell lymphoma (MCL) after receiving covalent bruton tyrosine kinase inhibitors (cBTKi) in China

Year: 2025
Type: conference-abstract
Source: Blood
Language: English
Field: Medicine
Open Access status: closed
OpenAlex ID: W4417017097
Cites:
Cited by:
Related to: